Please login to the form below

Not currently logged in
Email:
Password:

J&J to bring subsidiaries under one name

Johnson & Johnson is to bring its autonomous pharmaceutical subsidiaries under the name Janssen Pharmaceuticals by the end of 2011, with further plans to link its consumer and prescription marketing

US-based pharmaceutical and healthcare company Johnson & Johnson (J&J) is to bring its autonomous pharmaceutical subsidiaries under the Janssen Pharmaceuticals brand by the end of 2011.

As reported by the Financial Times, vice-chair at J&J, Sheri McCoy, said the names of companies acquired by J&J will be dropped in favour of the single identity.

Subsidiaries affected include the recently Centocor and Cilag, as well as Tibotec, which announced yesterday it would be operating under the name Janssen Therapeutics. All Tibotec brand names and organisational structures will remain in place and unchanged.

As well as the brand changes, McCoy also announced plans for greater linking between marketing activities for its prescription and consumer products.

Pilot projects have been arranged to market over-the-counter and prescription products together according to McCoy, with therapy areas under consideration including skincare and baby products.

J&J's pharmaceuticals business generated $22.4bn in sales during 2010, representing 36 per cent of J&J's total revenue.

McCoy is a possible successor to lead J&J, with current chair William Weldon likely to step down next year following the relaunch of several products recalled over 2010.

28th June 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...
InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...

Infographics